Laufs U - Search Results

1

Renal denervation in the treatment of hypertension.

Ukena C, Mahfoud F, Ewen S, Cremers B, Laufs U, Böhm M. Ukena C, et al. Among authors: laufs u. Curr Hypertens Rep. 2013 Aug;15(4):363-9. doi: 10.1007/s11906-013-0363-2. Curr Hypertens Rep. 2013. PMID: 23740362 Review.

2

Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.

Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Böhm MP. Nickenig G, et al. Among authors: laufs u. Br J Pharmacol. 1997 May;121(1):134-40. doi: 10.1038/sj.bjp.0701088. Br J Pharmacol. 1997. PMID: 9146897 Free PMC article.

3

[New findings on the action of HMG-CoA-reductase inhibitors].

Laufs U, Böhm M, Liao JK. Laufs U, et al. Dtsch Med Wochenschr. 1997 Oct 10;122(41):1255-9. doi: 10.1055/s-2008-1047756. Dtsch Med Wochenschr. 1997. PMID: 9378055 Review. German. No abstract available.

4

Vascular beta-adrenergic receptor adenylyl cyclase system from renin-transgenic hypertensive rats.

Sitzler G, Zolk O, Laufs U, Paul M, Böhm M. Sitzler G, et al. Among authors: laufs u. Hypertension. 1998 May;31(5):1157-65. doi: 10.1161/01.hyp.31.5.1157. Hypertension. 1998. PMID: 9576129

5

Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite.

Flesch M, Kilter H, Cremers B, Laufs U, Südkamp M, Ortmann M, Müller FU, Böhm M. Flesch M, et al. Among authors: laufs u. J Am Coll Cardiol. 1999 Mar 15;33(4):1062-70. doi: 10.1016/s0735-1097(98)00660-3. J Am Coll Cardiol. 1999. PMID: 10091837 Free article.

6

[The cardiovascular risk factor in obesity].

Laufs U, Böhm M. Laufs U, et al. Dtsch Med Wochenschr. 2000 Mar 3;125(9):262-8. doi: 10.1055/s-2007-1024089. Dtsch Med Wochenschr. 2000. PMID: 10742819 Review. German. No abstract available.

7

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.

Laufs U, Gertz K, Huang P, Nickenig G, Böhm M, Dirnagl U, Endres M. Laufs U, et al. Stroke. 2000 Oct;31(10):2442-9. doi: 10.1161/01.str.31.10.2442. Stroke. 2000. PMID: 11022078

8

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Böhm M. Laufs U, et al. Circulation. 2000 Dec 19;102(25):3104-10. doi: 10.1161/01.cir.102.25.3104. Circulation. 2000. PMID: 11120702

9

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

Wassmann S, Laufs U, Bäumer AT, Müller K, Konkol C, Sauer H, Böhm M, Nickenig G. Wassmann S, et al. Among authors: laufs u. Mol Pharmacol. 2001 Mar;59(3):646-54. doi: 10.1124/mol.59.3.646. Mol Pharmacol. 2001. PMID: 11179461

10

[Statins as new therapeutic possibility in osteoporosis?].

Laufs U, Werner N, Böhm M, Nickenig G. Laufs U, et al. Dtsch Med Wochenschr. 2001 May 11;126(19):565-8. doi: 10.1055/s-2001-13809. Dtsch Med Wochenschr. 2001. PMID: 11402915 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

590 results

Search Page

Filters